Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Bode

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
The American Journal of Managed Care|April 27, 2011
Liraglutide: a review of the first once-daily GLP-1 receptor agonistBruce Bode
Diabetes Research and Clinical Practice|January 17, 2012
An overview of the pharmacokinetics, efficacy and safety of liraglutideBruce Bode
Hospital Practice (1995)|August 20, 2010
Incretin-based therapies: review of the outpatient literature with implications for use in the hospital and after dischargeBruce Bode, Alpesh Amin
Clinical Therapeutics|November 20, 2009
Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trialSimon Heller, Christoph Koenen, Bruce Bode
Clinical Diabetes : a Publication of the American Diabetes Association|November 16, 2022
Can Faster Aspart Be Used to Optimize Glycemic Control With Insulin Pump Therapy? From Expectations to Lessons Learned After a Year of Use in the United StatesGrazia Aleppo, Bruce Bode, Anders L Carlson
Journal of Diabetes Science and Technology|December 19, 2017
Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 YearBruce Bode, John G Clarke, Joseph Johnson
The Diabetes Educator|August 26, 2010
Understanding GLP-1 analogs and enhancing patients successDavida F Kruger, Bruce Bode, Geralyn R Spollett
Managed Care (Langhorne, Pa.)|September 10, 2008
Evaluation of a continuous glucose monitoring system for home-use conditionsBruce Bode, Michael Silver, Richard Weiss, et al.
Journal of Diabetes|April 17, 2013
Meta-analysis of insulin aspart versus regular human insulin used in a basal-bolus regimen for the treatment of diabetes mellitusSimon Heller, Bruce Bode, Plamen Kozlovski, et al.
Expert Review of Medical Devices|November 13, 2015
Moving toward the ideal insulin for insulin pumpsEda Cengiz, Bruce Bode, Michelle Van Name, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
The American Journal of Managed Care|April 27, 2011
Liraglutide: a review of the first once-daily GLP-1 receptor agonistBruce Bode
Diabetes Research and Clinical Practice|January 17, 2012
An overview of the pharmacokinetics, efficacy and safety of liraglutideBruce Bode
Hospital Practice (1995)|August 20, 2010
Incretin-based therapies: review of the outpatient literature with implications for use in the hospital and after dischargeBruce Bode, Alpesh Amin
Clinical Therapeutics|November 20, 2009
Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trialSimon Heller, Christoph Koenen, Bruce Bode
Clinical Diabetes : a Publication of the American Diabetes Association|November 16, 2022
Can Faster Aspart Be Used to Optimize Glycemic Control With Insulin Pump Therapy? From Expectations to Lessons Learned After a Year of Use in the United StatesGrazia Aleppo, Bruce Bode, Anders L Carlson
Journal of Diabetes Science and Technology|December 19, 2017
Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 YearBruce Bode, John G Clarke, Joseph Johnson
The Diabetes Educator|August 26, 2010
Understanding GLP-1 analogs and enhancing patients successDavida F Kruger, Bruce Bode, Geralyn R Spollett
Managed Care (Langhorne, Pa.)|September 10, 2008
Evaluation of a continuous glucose monitoring system for home-use conditionsBruce Bode, Michael Silver, Richard Weiss, et al.
Journal of Diabetes|April 17, 2013
Meta-analysis of insulin aspart versus regular human insulin used in a basal-bolus regimen for the treatment of diabetes mellitusSimon Heller, Bruce Bode, Plamen Kozlovski, et al.
Expert Review of Medical Devices|November 13, 2015
Moving toward the ideal insulin for insulin pumpsEda Cengiz, Bruce Bode, Michelle Van Name, et al.
Pageof 7